Cure8 research brief
Why This Matters
Vitamin D may support intestinal barrier integrity and immune regulation—pathways central to mucosal healing and disease control in IBD. Understanding the evidence helps patients and clinicians consider vitamin D as a complementary part of care rather than a proven mucosal-healing therapy.
Who Should Pay Attention
People with IBD (Crohn’s disease or ulcerative colitis), clinicians treating IBD, and researchers focused on immune pathways and the microbiome.
Study Snapshot
What To Know
This review summarizes evidence on vitamin D’s roles in mucosal healing and gut health in IBD, focusing on immune modulation, intestinal barrier integrity, and effects on the microbiome. The authors report stronger preclinical and mechanistic data than definitive clinical proof that vitamin D supplementation induces endoscopic or histologic mucosal healing.
Clinical studies cited in the review more commonly show improvements in clinical indices and biochemical markers rather than clear, consistent endoscopic or histologic mucosal repair. The optimal vitamin D dosing and whether supplementation can produce true mucosal healing in IBD remain unclear.
If you are considering vitamin D for IBD, discuss testing and supplementation with your clinician; the review frames vitamin D as a potentially complementary, not standalone, therapy.
Keep In Mind
The review highlights mechanistic and preclinical support for vitamin D but notes that clinical trials often rely on symptomatic or biochemical measures rather than direct endoscopic or histologic mucosal-healing endpoints; optimal dosing for mucosal healing is not established.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.